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PURPOSE. Retinal microvasculopathy may reflect small vessel disease in the brain. Here we test
the relationships between retinal vascular parameters and small vessel disease, the influence
of cardiovascular risk factors on these relationships, and their common genetic background in
a monozygotic twin cohort.
METHODS. We selected 134 cognitively healthy individuals (67 monozygotic twin pairs) aged
‡60 years from the Netherlands Twin Register for the EMIF-AD PreclinAD study. We measured
seven retinal vascular parameters averaged over both eyes using fundus images analyzed with
Singapore I Vessel Assessment. Small vessel disease was assessed on MRI by a volumetric
measurement of periventricular and deep white matter hyperintensities. We calculated
associations between RVPs and WMH, estimated intratwin pair correlations, and performed
twin-specific analyses on relationships of interest.
RESULTS. Deep white matter hyperintensities volume was positively associated with retinal
tortuosity in veins (P ¼ 0.004) and fractal dimension in arteries (P ¼ 0.001) and veins (P ¼
0.032), periventricular white matter hyperintensities volume was positively associated with
retinal venous width (P ¼ 0.028). Intratwin pair correlations were moderate to high for all
small vessel disease/retinal vascular parameter variables (r ¼ 0.49–0.87, P < 0.001). Cross-
twin cross-trait analyses showed that retinal venous tortuosity of twin 1 could predict deep
white matter hyperintensities volume of the co-twin (r ¼ 0.23, P ¼ 0.030). Within twin-pair
differences for retinal venous tortuosity were associated with within twin-pair differences in
deep white matter hyperintensities volume (r ¼ 0.39, P ¼ 0.001).
CONCLUSIONS. Retinal arterial fractal dimension and venous tortuosity have associations with
deep white matter hyperintensities volume. Twin-specific analyses suggest that retinal venous
tortuosity and deep white matter hyperintensities volume have a common etiology driven by
both shared genetic factors and unique environmental factors, supporting the robustness of
this relationship.
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The eye, and especially the retina, may reflect vascularpathology elsewhere in the body, and is easily assessable
through direct imaging like fundus photography. Subtle
changes of the microvasculature of the retina, such as retinal
vessel diameter changes or increased tortuosity, can be
measured using automated detection software on fundus
photographs.1
The retina shares many similarities with the brain, being
embryologically derived from the same tissue and possessing
similar structural and functional features such as a blood–retina
barrier and glial cell connections.2 This makes the eye an ideal
potential biomarker for vascular and degenerative processes
occurring in the brain.2–6 Many degenerative diseases of the
brain also contain a vascular component. Vascular dementia is
an obvious example, but also in diseases such as Alzheimer’s
disease, vascular changes play an important role.7,8 These
pathologic vascular changes of the brain are summarized under
the term cerebral small vessel disease, such as white matter
hyperintensities on MRI.9–11 White matter hyperintensities are
commonly observed white spots in the cerebral white matter of
especially elderly people on MRI and are thought to reflect
(micro)vascular damage.12 Several groups have found relation-
ships between retinal vascular parameters and cerebral small
vessel disease, especially in people predisposed to cerebral
small vessel disease.13–18
Vascular changes in the eye and the brain show a moderate
to high level of genetic influence.19 Heritability (variation
explained by the genome) estimates lie between 0.49 and 0.83
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for ophthalmologic vascular parameters20–23 and between 0.64
and 0.77 for small vessel disease.24–27 By performing a study on
monozygotic twins, we aimed to elucidate the genetic and
environmental influence on possible relationships between
these two vascular systems. For this purpose, two sets of
analyses will be performed; a cross-twin cross trait and a twin-
difference analysis. A cross-twin cross-trait analysis takes the
trait of twin 1 to predict a different trait of the co-twin. If a
relationship is found, this suggests that the relationship
between said traits is at least partially explained by shared
factors, either genetic or environmental, between the twins.28
A twin-difference analysis correlates the within twin-pair
differences of a continuous trait to the within twin-pair
differences in a second trait. If a relationship between these
differences is found, this suggests a unique environmental
factor mediating both traits, as differences within monozygotic
twins can only be due to environmental exposures that are not
shared by twins. If there is a causal relationship between the
two traits and the causal trait is partly genetic, and partly
environmental, difference scores will also be correlated.29
A confounding factor in the relationship between vascula-
ture in the eye and the brain is systemic disease, as systemic
vascular disease shows relationships to both retinal vessel
parameters as well as brain small vessel disease. For example,
hypertension has been shown to be associated with decreased
arteriolar diameter,30–34 and a smaller arteriovenous ratio was
found to be related to atherosclerotic findings35,36 and an
increased chance of developing diabetes mellitus.37,38 Addi-
tionally, it is known that cardiovascular risk factors such as
hypertension play an important role in the development of
cerebral small vessel disease.39,40
In this study, we aimed to (1) test the associations between
retinal vascular parameters and small vessel disease in the
context of cardiovascular risk factors, (2) estimate the upper
limit of the genetic contribution to retinal vascular parameters
and small vessel disease in a population of healthy, elderly,
monozygotic twins, and (3) investigate the underlying mech-
anism of the associations between retinal vascular parameters




We invited 217 participants aged ‡60 years from the Nether-
lands Twin Register27,41 who take part in the Amsterdam
substudy of the European Medical Information Framework for
Alzheimer’s Disease (EMIF-AD) PreclinAD cohort. The study
followed the Tenets of the Declaration of Helsinki, and written
informed consent was obtained from all participants. The study
was approved by the Medical Ethics Committee of the VU
University Medical Center in Amsterdam.
Inclusion criteria were as follows: monozygosity, age ‡ 60
years; cognitively healthy as defined by Telephone Interview
for Cognitive Status modified (TICS-m) score >2242; Geriatric
Depression Scale (GDS) score <1143; Consortium to Establish a
Registry for Alzheimer’s Disease (CERAD) 10-word list imme-
diate and delayed recall >1.5 SD of age-adjusted normative
data44; and Clinical Dementia Rating (CDR) scale of 0 with a
score on the memory sub domain of 0.45
Exclusion criteria were as follows: stroke resulting in
physical impairment, neurodegenerative disorders, cancer
with terminal life expectancy, uncontrolled diabetes mellitus,
and alcohol consumption >35 units (1 unit¼10 mL or 8 g pure
alcohol) per week.
Cardiovascular Risk Factors
Clinical data were collected during a face-to-face interview for
medical history, medication intake, smoking habits, and
educational attainment. All participants also underwent
physical examinations. Blood pressure was measured three
times in a lying position with a 5-minute interval between
measurements, and the mean of these three measurements was
used for the analysis. After a minimum 2-hour fasting period,
participants underwent a blood draw to determine lipid profile
and glycated hemoglobin in the morning. The cardiovascular
risk profile for each participant was summarized using the
Framingham Risk Score, which includes the following factors:
age, sex, total cholesterol, high-density lipoprotein (HDL),
systolic blood pressure, antihypertensive medication use,
diabetes mellitus, and smoking.46 This risk index represents
the 10-year risk of a major cardiovascular event.
Ophthalmologic Examination
All participants underwent the following ophthalmologic
examinations: best-corrected visual acuity, IOP, refraction data,
slit-lamp examination, indirect fundoscopy, and fundus pho-
tography. Tropicamide 0.5% was used for pupil dilation to
enable these examinations. All photographs were assessed by
an experienced ophthalmologist (HTN) for unexpected pa-
thology. Participants suffering from ophthalmologic conditions
interfering with retinal vasculature or image quality were
excluded from analysis (cataract, macular degeneration,
glaucoma, diabetic retinopathy, vascular occlusions), as well
as ungradable images.
Fundus Photography and Quantitative Assessment
of Retinal Vasculature
Digital fundus images of 508 field of view were obtained from
both eyes of most participants (Topcon TRC 50DX type IA;
Topcon Medical Systems, Inc., Oakland, CA, USA), centered on
the optic nerve head. These images were graded by a trained
grader (JAvdK) using the Singapore I Vessel Assessment (SIVA)
software (version 3.0; National University of Singapore,
Singapore).47–49 Values from both eyes of every participant
were averaged; if only one suitable image was present, only this
eye was included. Intrarater scores were calculated in 20
patients. Based on this, we selected seven mostly dimension-
less retinal vascular parameters to account for refraction error
with an intraobserver intraclass correlation, absolute agree-
ment, of >0.80 for the analyses. These are central retinal artery
equivalent, central retinal vein equivalent, arteriole–venular
ratio, fractal dimension of the arteriolar network, fractal
dimension of the venular network, curvature tortuosity of
the arterioles, and curvature tortuosity of the venules. All
values for retinal vascular parameters were obtained within
zone C (i.e., 0.5 to 2 disc diameters around the optic nerve
head).
Magnetic Resonance Imaging
Whole brain scans were obtained using a 3T scanner using an
eight-channel head coil (Philips Ingenuity Time-of-Flight PET/
MRI-scanner; Philips Medical Systems, Best, Netherlands).
Isotropic structural three-dimensional (3D) T1-weighted imag-
es (1.00-mm3 isotropic voxels, repetition time [TR] ¼ 7.9 ms,
echo time [TE] ¼ 4.5 ms, flip angle ¼ 88) and 3D sagittal Fluid
Attenuated Inversion Recovery sequences (1.12-mm3 isotropic
voxels, TR¼ 4800 ms, TE¼ 279 ms, inversion time¼ 1650 ms)
were acquired. An experienced neuroradiologist visually
assessed all scans for incidental findings.
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The scans were visually rated by a single experienced rater
(MtK), who was blinded to twin pairing.
Cerebral small vessel disease was assessed by white matter
hyperintensities, using 3D sagittal FLAIR on magnetic reso-
nance imaging (MRI). White matter hyperintensities were
automatically segmented using a previously described algo-
rithm.27,50 In short, the algorithm can make a distinction
between different types of abnormal image patterns without
pathologic a priori knowledge, enabling detection of abnormal
intensity clusters, which is particularly useful in segmenting
white matter hyperintensities. The white matter hyperinten-
sities map was then dichotomized into periventricular and
deep regions using the relative distance between the ventric-
ular surface and the cortical sheet at a ratio of 50%/50%.
Total intracranial volume measurements were obtained
from the application of a label fusion algorithm.51
Statistical Analysis
To normalize the distribution for white matter hyperintensities
volume and arterial and venular tortuosity, a log transformation
was applied. White matter hyperintensities were further
corrected for head size using the total intracranial volume.
Analyses with these as dependent variables are thus reported
in ratios instead of regression coefficients. A ratio can take any
value from 0 onward, where 1 means there is no relationship,
<1 means there is a negative relationship (i.e., with an increase
in the independent variable, the dependent variable will
decrease), and >1 means there is a positive relationship (i.e.,
with an increase in the independent variable, the dependent
variable will also increase). Relationships between retinal
vascular parameters, white matter hyperintensities, and
cardiovascular risk factors were investigated with generalized
estimating equations (GEE) using SPSS (version 22; IBM,
Chicago, IL, USA), to correct for clustering in the data from
twin pairs, as well as confounders such as age and sex.
Monozygotic siblings are very much alike and should thus not
be treated as separate individuals, GEE is a type of regression
analysis which can take such dependencies into account.
Intratwin pair correlations were calculated using Pearson/
Spearman correlation coefficients. An intratwin pair correla-
tion is the correlation between the two siblings within a twin
pair. One would thus expect this correlation to be high when a
trait is mainly determined by shared factors, of either genetic or
environmental etiology. Cross-twin cross-trait analyses, which
use the trait of twin 1 to predict a different trait of the co-twin,
were performed using structural equation modeling imple-
mented in OpenMx running in RStudio (version 1.1.383;
RStudio, Inc., Boston, MA, USA). Twin difference analyses were
performed by using SPSS. Cross-twin cross-trait and twin
difference analyses were performed on significant relationships
between retinal vascular parameters and white matter hyper-
intensities only. Analyses were corrected for age and sex, and
standardized values for retinal fractal dimension of the veins
and retinal tortuosity of both veins and arteries were used for
the cross-twin cross-trait analyses. Standardizing values means
making a Z-score out of a parameter (with a mean of 0 and SD
of 1.96). We applied a standardization to some parameters for
this particular analysis, because the script used for this analysis
has trouble in dealing with values of a very different size (in
this case comparing very small values to values around 3).
RESULTS
Of the 217 approached subjects, 15 were excluded due to:
epileptic seizures (N¼ 1), heart problems (N¼ 1), not meeting
neuropsychologic inclusion criteria (N¼ 3), neurodegenerative
disease (N¼ 2), conditions disabling a hospital study visit (N¼
4), transient ischemic attacks (N¼ 1), or being a sibling to one
of the excluded cases (N ¼ 3), leaving a total of 202
participants (100 monozygotic twin pairs and 2 singletons).
Of these, 12 were excluded from analyses due to ophthalmo-
logic disease. Of the remaining 190 participants, only 134
participants (67 twin pairs) were complete pairs who had
useable data for most included parameters (i.e., sufficient
quality fundus pictures and MRI data, complete Framingham
Risk Score). This subset was demographically very similar to
the whole population. Table 1 shows the demographics of the
population in this study.
After correction for clustering, age, sex, and total intracra-
nial volume, only increased central retinal vein equivalent was
related to a higher volume of periventricular white matter
hyperintensities (Table 2).
An increased fractal dimension of arteries and veins and
increased tortuosity of veins were related to deep white matter
hyperintensities volume. Table 2 shows all the associations
between retinal vascular parameters and white matter hyper-
intensities volumes.
To look for possible mediating cardiovascular risk factors in
the above described relationships, cardiovascular risk factors
were analyzed in relation to both retinal vascular parameters
and small vessel disease (Supplementary Table S1). None of the
cardiovascular risk factors were significantly related to both
the retinal vascular parameters and small vessel disease in any
of the relationships described above. When we repeated the
analyses of the associations between retinal vascular parame-
ters and small vessel disease with correction for Framingham
risk score, the associations remained similar (Supplementary
Table S2).
The intratwin pair correlations were moderate to high for
all small vessel disease/retinal vascular parameters variables
(Table 3).
For the associations found between the retinal vascular
parameters and small vessel disease (Table 2), we performed
cross-twin cross-trait and twin difference analysis. Cross-twin
cross-trait analysis showed a relationship between retinal
tortuosity of the veins of twin 1 with deep white matter
hyperintensities volume of the co-twin (r ¼ 0.23, P ¼ 0.030;
Table 4), whereas other markers showed a trend (P » 0.1;
Table 5).
Within twin-pair differences for retinal venous tortuosity
were related to within twin-pair differences in deep white
matter hyperintensities volume (r ¼ 0.39, P ¼ 0.001; Table 5).
DISCUSSION
Increased tortuosity of retinal veins and increased fractal
dimension of retinal arteries and veins were related to a higher
volume of deep white matter hyperintensities. An increase in
the width of retinal veins was associated with a higher volume
of periventricular white matter hyperintensities. Retinal venous
tortuosity was also associated to deep white matter hyper-
intensities in cross-twin cross-trait and twin difference analysis,
suggesting that these vascular changes have a shared underlying
factor related to genetic and nonshared environmental factors.
We found that retinal venous tortuosity was positively
associated with deep white matter hyperintensities volume. In
the retina, increased vascular tortuosity is thought to be
indicative of vessel wall dysfunction, tissue hypoxia, disturbed
blood–retina barrier, and disturbed blood flow.52 Similar
mechanisms have been described to lead to white matter
hyperintensities in the brain,53 suggesting similar processes on
a microvascular level are occurring in synchrony in both the
eye and the brain. This was supported by cross-twin cross-trait
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and twin-difference analyses. Cross-twin cross-trait analyses
showed that the retinal venous tortuosity of twin 1 was
associated with deep white matter hyperintensities volume of
the co-twin. This means that the relationship between these
traits is partly explained by shared factors between the twins.28
It is likely that in our elderly cohort, age 60 years and older, the
association is mainly explained by genetic factors, as discussed
below. Twin difference analysis showed that within twin-pair
differences for retinal venous tortuosity were related to within
twin-pair differences in deep white matter hyperintensities
volume. As any difference between monozygotic twins is due
to environmental factors unique to each twin; this means that
the association is also driven by nonshared environmental
factors, possibly supporting a causal relationship between
these traits.29 As a direct causal influence of one trait on the
other is unlikely in our case, our results suggest there is a
common unique environmental factor influencing both retinal
venous tortuosity and deep white matter hyperintensities
volume, in addition to shared genetic factors.
An increase in retinal venous tortuosity has been found to
be associated with hypertension.49 Hypertension also has a
relationship to white matter hyperintensities volume,54 so it
would seem likely that the relationship between retinal venous
tortuosity and white matter hyperintensities volume was
driven through hypertension. Yet, a diagnosis of hypertension
did not show a relationship to venous tortuosity in our study
(Supplementary Table S1), and adding Framingham risk score
to our model did not change the significance of the
relationship found between venous tortuosity and deep white
matter hyperintensities volume (Supplementary Table S2). This
suggests there is a relationship between the tortuosity of veins
in the retina and deep white matter hyperintensities volume
regardless of cardiovascular risk factors such as hypertension.
Our finding that increased fractal dimension in the retina
was associated with higher volume of deep white matter
hyperintensities was unexpected. Reduced fractal dimension
has been associated with stroke, cognitive dysfunction, and
hypertension3,48,55–59 and is thought to represent microvascu-
lar damage, due to destruction and collapse of small vessels,
thus creating a ‘‘simpler’ network.’’60 As white matter hyper-
intensities also represents vascular damage,53 one would
expect that decreased retinal fractal dimension is associated
with higher white matter hyperintensities volume, rather than
the opposite. An explanation could be a physiologic variation
in the fractal dimension of the retinal vasculature. It may be
that those who are born with a more complex network of
retinal vessels may have a different makeup of vessels in the
brain as well, which makes individuals more vulnerable to the
development of white matter hyperintensities.
Cross-twin cross-trait and twin difference analysis did not
show any associations, suggesting that the association between
fractal dimension and deep white matter hyperintensities does
not have a shared etiology.
TABLE 1. Demographics From Study Population
Parameters N/Means
Total participants 134
Age, y 69.9 (67.8)
Sex, female N (%) 72 (53.7%)
Best-corrected visual acuity (LogMAR) 0.02 (60.10)
IOP (mm Hg) 14.2 (62.4)
Spherical equivalent (both eyes averaged) 0.27 (61.9)
Mini Mental State Examination 29.0 (61.2)
Cardiovascular risk factors
Hypertension, N (%) 49 (36.6%)
Diabetes mellitus type 2, N (%) 6 (4.5%)
Mean arterial pressure (mm Hg) 107.2 (611.2)
Smoking, N (%) 16 (11.9%)
Body mass index (kg/m2) 25.9 (63.6)
Framingham risk score 26.7 (614.9)
White matter hyperintensities (WMH)
Periventricular WMH volume (mm3) 3,020 (63,891)
Deep WMH volume (mm3) 1,832 (63,054)
Total intracranial volume (mm3) 1,397,626 (6125,704)
Retinal vascular parameters
Central retinal artery equivalent 127.5 (611.8)
Central retinal vein equivalent 196.8 (619.0)
Arteriole–venular ratio 0.651 (60.054)
Fractal dimension of arteries 1.176 (60.047)
Fractal dimension of veins 1.157 (60.049)
Curvature tortuosity of arteries (3104) 0.632 (60.165)
Curvature tortuosity of veins (3104) 0.640 (60.155)
Data are means unless otherwise specified.
TABLE 2. Associations Between Retinal Vascular Parameters and WMH, Given in Ratios Due to a Log Transformation Applied to the Dependent
Variables
Periventricular WMH Volume, Ratio,
P Value (95% CI of Ratio)
Deep WMH Volume, Ratio,
P Value (95% CI of Ratio)
Central retinal artery equivalent* 1.690, P ¼ 0.459
(0.421 to 6.792)
1.429, P ¼ 0.657
(0.296 to 6.918)
Central retinal vein equivalent* 2.799, P ¼ 0.028
(1.119 to 6.998)
1.888, P ¼ 0.274
(0.605 to 5.888)
Arteriole-venular ratio 0.129, P ¼ 0.167
(0.007 to 2.360)
0.256, P ¼ 0.438
(0.008 to 7.980)
Fractal dimension of arteries 1.622, P ¼ 0.774
(0.060 to 43.954)
317.687, P ¼ 0.001
(12.246 to 8241.381)
Fractal dimension of veins 4.529, P ¼ 0.393
(0.141 to 145.546)
36.224, P ¼ 0.032
(1.352 to 970.510)
Curvature tortuosity of arteries† 1.982, P ¼ 0.273
(0.583 to 6.730)
3.100, P ¼ 0.088
0.845 to 11.376
Curvature tortuosity of veins† 2.937, P ¼ 0.116
(0.765 to 11.267)
7.995, P ¼ 0.004
1.967 to 32.486
Bold values are significant at P < 0.05. Generalized estimating equations, corrected for age, sex, and total intracranial volume. Brain parameters
were chosen as the dependent variables.
* Reported in steps of 100.
† Reported in steps of 104.
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We found that increased venous width (central retinal vein
equivalent) was associated with increased periventricular white
matter hyperintensities volume. Other studies have shown that
increased central retinal vein equivalent was related to
cardiovascular risk factors such as hypertension, diabetes, and
smoking behavior.31,61,62 It is postulated that widening of the
venules may reflect endothelial dysfunction, and it is hypothe-
sized to be a general marker of retinal ischemia and
hypoperfusion.62 Our results are in line with this; white matter
hyperintensities represent (micro)vascular damage in the brain,
and an increase in central retinal vein equivalent in the eye
could suggest a similar process occurring in the eye.
Cross-twin cross-trait and twin difference analysis did not
show any associations, suggesting that the association between
retinal venous width and deep white matter hyperintensities
does not have a shared etiology.
Interestingly, most relationships between the eye and brain
in this study were found with deep white matter hyper-
intensities, rather than periventricular white matter hyper-
intensities. Periventricular white matter hyperintensities has
been shown to have a stronger association with cardiovascular
risk factors, as it is supposed to be particularly vulnerable to
decreases in blood flow due to it being anatomically located at
the arterial border zone.63 This was confirmed by our study;
after correction for multiple confounders, only periventricular
white matter hyperintensities showed significant relationships
with smoking behavior and Framingham risk score (Supple-
mentary Table S1). As both periventricular white matter
hyperintensities and microvascular changes of the eye are
associated with cardiovascular risk factors, one would expect
the relationship between microvascular changes in the eye to
be more strongly related to periventricular white matter
hyperintensities rather than deep white matter hyperinten-
sities. This suggests that the underlying pathophysiology of
retinal vascular parameters is likely to be heterogeneous.
For small vessel disease, we found high intratwin pair
correlations ranging from 0.84 to 0.87. Other studies have found
similar contributions of genes to these parameters, with intratwin
pair correlations ranging from 0.74 to 0.77 in monozygotic twins,
corresponding to estimated heritabilities ranging from 0.64 to
0.77 for white matter hyperintensities lesions.25
For retinal vascular parameters, we found intratwin pair
correlations ranged from 0.49 to 0.71. This matches what was
found by other studies, as estimated intra twinpair correlations
of 0.51 to 0.88, with corresponding heritabilities ranging from
0.57 to 0.83, are reported.20–22,64
It was a strength of the study that all participants were very
well characterized, in both the neurologic and ophthalmologic
sense. Extensive screening was performed before inclusion of
the participants for analysis.
Another strength of the study was that we included the role
of cardiovascular risk factors in the relationships between the
eye and brain. Most other studies on this topic look at only the
relationship between eye–brain, eye–systemic, or brain–
systemic. In this study, we also looked at the relationship
between retinal vascular parameters and small vessel disease
when corrected for cardiovascular disease.
We did not include dizygotic twins and therefore could not
estimate the contribution of genetic factors and shared
environmental factors to the twin associations. In older twins,
however, the estimated contribution of shared environmental
effects is lower, as these twins have spent most of their life
apart. This is also the case for both white matter hyper-
intensities volume and retinal vascular parameters, as other
studies have shown very low contributions of the shared
environment on these parameters.20,21,25
We did not correct for multiple testing, as the nature of this
study was mostly explorative. However, several of the
relationships found in this study (venous tortuosity and deep
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TABLE 4. Cross-Twin Cross-Trait Correlations for Significant Relation-
















NA 0.16 (P ¼ 0.101)
Fractal dimension of
veins†






NA 0.23 (P ¼ 0.030)
Bold values are significant at P < 0.05. Dependent variables were
corrected for age, sex, and total intracranial volume. NA, not
applicable.
* 10Log transform applied.
† Standardized values used.
TABLE 5. Twin Difference Correlations for Significant Relationships
















NA 0.11 (P ¼ 0.392)
Fractal dimension of
veins






NA 0.39 (P ¼ 0.001)
Bold values are significant at P < 0.05. NA, not applicable.
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white matter hyperintensities volume, fractal dimension, and
deep white matter hyperintensities volume) were of such
significance that they would survive a correction for multiple
testing, suggesting a quite robust relationship.
It is very possible, and even highly likely, that other
systemic factors/cardiovascular risk factors we did not include
in our analyses are responsible for causing the relations found
within this study. The relations found are very unlikely to be of
a causative nature (i.e., vascular changes in the eye do not
cause changes in white matter hyperintensities volume in the
brain). It is thus likely that a common factor causes changes in
both these domains, explaining why a relation between the
two is found. We have tried to elucidate what factor this could
be by looking at some of the more obvious systemic
parameters. There are, however, infinitely more (systemic)
factors affecting the vascular state of the human body. It is
impossible to look at all cardiovascular risk factors known thus
far, so we limited our search to the more common ones (mostly
the ones also used to compile the Framingham risk score).
Additionally, our ultimate goal behind this study is to develop
an easy and noninvasive biomarker to gain more insight into
the vascular state of the brain. Regardless of what causes the
relation between the eye and brain parameters within this
study, if these eye parameters can be used to obtain
information we would otherwise have to use an MRI for, we
have already gained an invaluable biomarker.
In conclusion, this study showed that there was a
moderate to high correlation between monozygotic twins
for retinal vascular parameters and cerebral small vessel
disease, suggesting a relatively big contribution of genes to
these parameters. Furthermore, both fractal dimension of
arteries and veins as well as tortuosity of veins in the retina
were related to deep white matter hyperintensities, and
retinal venous width was related to periventricular white
matter hyperintensities. The relationship between venous
tortuosity and deep white matter hyperintensities volume was
also significant on a cross-twin cross-trait as well as a twin
difference analysis, giving us more insight into the nature of
this relationship, but also strongly supporting its robustness.
This relationship, in particular, may be of interest to explore
further, to elucidate whether retinal venous tortuosity may
have diagnostic properties in establishing those at risk of
small vessel disease, as obtaining information using the eye
can be a considerably more patient friendly and cheaper
alternative to MRI scanning.
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